Innate resistance to flavivirus infections and the functions of 2'-5' oligoadenylate synthetases.
Identifieur interne : 001B07 ( PubMed/Checkpoint ); précédent : 001B06; suivant : 001B08Innate resistance to flavivirus infections and the functions of 2'-5' oligoadenylate synthetases.
Auteurs : T. Mashimo [Japon] ; D. Simon-Chazottes ; J-L GuénetSource :
- Current topics in microbiology and immunology [ 0070-217X ] ; 2008.
Descripteurs français
- KwdFr :
- MESH :
- génétique : 2',5'-Oligoadenylate synthetase.
- immunologie : Infections à flavivirus.
- physiologie : 2',5'-Oligoadenylate synthetase.
- étiologie : Infections à flavivirus.
- Animaux, Humains, Immunité innée, Prédisposition génétique à une maladie, Souris.
English descriptors
- KwdEn :
- MESH :
- chemical , genetics : 2',5'-Oligoadenylate Synthetase.
- chemical , physiology : 2',5'-Oligoadenylate Synthetase.
- etiology : Flavivirus Infections.
- immunology : Flavivirus Infections.
- Animals, Genetic Predisposition to Disease, Humans, Immunity, Innate, Mice.
Abstract
Mouse susceptibility to experimental infections with flaviviruses is significantly influenced by a cluster of genes on chromosome 5 encoding a family of proteins with enzymatic properties, the 2'-5' oligoadenylate synthetases (OAS). Positional cloning of the locus in question has revealed that susceptibility of laboratory inbred strains to this class of virus is associated with a nonsense mutation in the gene encoding the OAS1B isoform. Analysis of the molecular structure of the cluster in different mammalian species including human indicates that the cluster is extremely polymorphic with a highly variable number of genes and pseudogenes whose functions are not yet completely established. Although still preliminary, a few recent observations also substantiate a possible role for OAS1 in human susceptibility to viral infections (West Nile virus, SARS, etc.) and its possible involvement in some other diseases such as type 1 diabetes and multiple sclerosis. Finally, convergent observations indicate that the molecules encoded by the 2 '-5' OAS cluster might be involved in other fundamental cellular functions such as cell growth and differentiation, gene regulation, and apoptosis.
DOI: 10.1007/978-3-540-75203-5_4
PubMed: 18727488
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:18727488Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Innate resistance to flavivirus infections and the functions of 2'-5' oligoadenylate synthetases.</title><author><name sortKey="Mashimo, T" sort="Mashimo, T" uniqKey="Mashimo T" first="T" last="Mashimo">T. Mashimo</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Laboratory Animals, Kyoto University Graduate School of Medicine, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Institute of Laboratory Animals, Kyoto University Graduate School of Medicine, Kyoto</wicri:regionArea><wicri:noRegion>Kyoto</wicri:noRegion></affiliation></author><author><name sortKey="Simon Chazottes, D" sort="Simon Chazottes, D" uniqKey="Simon Chazottes D" first="D" last="Simon-Chazottes">D. Simon-Chazottes</name></author><author><name sortKey="Guenet, J L" sort="Guenet, J L" uniqKey="Guenet J" first="J-L" last="Guénet">J-L Guénet</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="RBID">pubmed:18727488</idno><idno type="pmid">18727488</idno><idno type="doi">10.1007/978-3-540-75203-5_4</idno><idno type="wicri:Area/PubMed/Corpus">001A78</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A78</idno><idno type="wicri:Area/PubMed/Curation">001A78</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A78</idno><idno type="wicri:Area/PubMed/Checkpoint">001B07</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001B07</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Innate resistance to flavivirus infections and the functions of 2'-5' oligoadenylate synthetases.</title><author><name sortKey="Mashimo, T" sort="Mashimo, T" uniqKey="Mashimo T" first="T" last="Mashimo">T. Mashimo</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Laboratory Animals, Kyoto University Graduate School of Medicine, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Institute of Laboratory Animals, Kyoto University Graduate School of Medicine, Kyoto</wicri:regionArea><wicri:noRegion>Kyoto</wicri:noRegion></affiliation></author><author><name sortKey="Simon Chazottes, D" sort="Simon Chazottes, D" uniqKey="Simon Chazottes D" first="D" last="Simon-Chazottes">D. Simon-Chazottes</name></author><author><name sortKey="Guenet, J L" sort="Guenet, J L" uniqKey="Guenet J" first="J-L" last="Guénet">J-L Guénet</name></author></analytic><series><title level="j">Current topics in microbiology and immunology</title><idno type="ISSN">0070-217X</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>2',5'-Oligoadenylate Synthetase (genetics)</term><term>2',5'-Oligoadenylate Synthetase (physiology)</term><term>Animals</term><term>Flavivirus Infections (etiology)</term><term>Flavivirus Infections (immunology)</term><term>Genetic Predisposition to Disease</term><term>Humans</term><term>Immunity, Innate</term><term>Mice</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>2',5'-Oligoadenylate synthetase (génétique)</term><term>2',5'-Oligoadenylate synthetase (physiologie)</term><term>Animaux</term><term>Humains</term><term>Immunité innée</term><term>Infections à flavivirus (immunologie)</term><term>Infections à flavivirus (étiologie)</term><term>Prédisposition génétique à une maladie</term><term>Souris</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>2',5'-Oligoadenylate Synthetase</term></keywords><keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>2',5'-Oligoadenylate Synthetase</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Flavivirus Infections</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>2',5'-Oligoadenylate synthetase</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à flavivirus</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Flavivirus Infections</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>2',5'-Oligoadenylate synthetase</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Infections à flavivirus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Genetic Predisposition to Disease</term><term>Humans</term><term>Immunity, Innate</term><term>Mice</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Humains</term><term>Immunité innée</term><term>Prédisposition génétique à une maladie</term><term>Souris</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Mouse susceptibility to experimental infections with flaviviruses is significantly influenced by a cluster of genes on chromosome 5 encoding a family of proteins with enzymatic properties, the 2'-5' oligoadenylate synthetases (OAS). Positional cloning of the locus in question has revealed that susceptibility of laboratory inbred strains to this class of virus is associated with a nonsense mutation in the gene encoding the OAS1B isoform. Analysis of the molecular structure of the cluster in different mammalian species including human indicates that the cluster is extremely polymorphic with a highly variable number of genes and pseudogenes whose functions are not yet completely established. Although still preliminary, a few recent observations also substantiate a possible role for OAS1 in human susceptibility to viral infections (West Nile virus, SARS, etc.) and its possible involvement in some other diseases such as type 1 diabetes and multiple sclerosis. Finally, convergent observations indicate that the molecules encoded by the 2 '-5' OAS cluster might be involved in other fundamental cellular functions such as cell growth and differentiation, gene regulation, and apoptosis.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18727488</PMID><DateCompleted><Year>2008</Year><Month>09</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0070-217X</ISSN><JournalIssue CitedMedium="Print"><Volume>321</Volume><PubDate><Year>2008</Year></PubDate></JournalIssue><Title>Current topics in microbiology and immunology</Title><ISOAbbreviation>Curr. Top. Microbiol. Immunol.</ISOAbbreviation></Journal><ArticleTitle>Innate resistance to flavivirus infections and the functions of 2'-5' oligoadenylate synthetases.</ArticleTitle><Pagination><MedlinePgn>85-100</MedlinePgn></Pagination><Abstract><AbstractText>Mouse susceptibility to experimental infections with flaviviruses is significantly influenced by a cluster of genes on chromosome 5 encoding a family of proteins with enzymatic properties, the 2'-5' oligoadenylate synthetases (OAS). Positional cloning of the locus in question has revealed that susceptibility of laboratory inbred strains to this class of virus is associated with a nonsense mutation in the gene encoding the OAS1B isoform. Analysis of the molecular structure of the cluster in different mammalian species including human indicates that the cluster is extremely polymorphic with a highly variable number of genes and pseudogenes whose functions are not yet completely established. Although still preliminary, a few recent observations also substantiate a possible role for OAS1 in human susceptibility to viral infections (West Nile virus, SARS, etc.) and its possible involvement in some other diseases such as type 1 diabetes and multiple sclerosis. Finally, convergent observations indicate that the molecules encoded by the 2 '-5' OAS cluster might be involved in other fundamental cellular functions such as cell growth and differentiation, gene regulation, and apoptosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mashimo</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Laboratory Animals, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon-Chazottes</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Guénet</LastName><ForeName>J-L</ForeName><Initials>JL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Curr Top Microbiol Immunol</MedlineTA><NlmUniqueID>0110513</NlmUniqueID><ISSNLinking>0070-217X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.7.84</RegistryNumber><NameOfSubstance UI="D015088">2',5'-Oligoadenylate Synthetase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015088" MajorTopicYN="N">2',5'-Oligoadenylate Synthetase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018177" MajorTopicYN="N">Flavivirus Infections</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>47</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>8</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>9</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>8</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18727488</ArticleId><ArticleId IdType="doi">10.1007/978-3-540-75203-5_4</ArticleId><ArticleId IdType="pmc">PMC7122621</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 1982 Oct 15;108(3):1243-50</Citation><ArticleIdList><ArticleId IdType="pubmed">6185117</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Diabetes. 2006 May;55(5):1525-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16644715</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9322-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12080145</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Interferon Cytokine Res. 2002 Sep;22(9):981-93</Citation><ArticleIdList><ArticleId IdType="pubmed">12396720</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Interferon Cytokine Res. 1998 Nov;18(11):987-97</Citation><ArticleIdList><ArticleId IdType="pubmed">9858321</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Mamm Genome. 2001 Apr;12(4):261-71</Citation><ArticleIdList><ArticleId IdType="pubmed">11309656</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>FEBS Lett. 1999 Nov 26;462(1-2):12-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10580083</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Biol Chem. 1997 Dec 26;272(52):33220-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9407111</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Tissue Antigens. 2006 Nov;68(5):446-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17092260</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>BMC Infect Dis. 2006 Jul 06;6:106</Citation><ArticleIdList><ArticleId IdType="pubmed">16824203</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochimie. 2007 Jun-Jul;89(6-7):779-88</Citation><ArticleIdList><ArticleId IdType="pubmed">17408844</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Gen Virol. 1999 Apr;80 ( Pt 4):897-906</Citation><ArticleIdList><ArticleId IdType="pubmed">10211958</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nucleic Acids Res. 1998 Sep 15;26(18):4121-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9722630</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Biotechnol. 1996 Nov;14(11):1566-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9634822</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Diabetes. 2005 May;54(5):1588-91</Citation><ArticleIdList><ArticleId IdType="pubmed">15855350</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11311-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12186974</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Arch Virol. 2003 May;148(5):1017-26</Citation><ArticleIdList><ArticleId IdType="pubmed">12721807</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Infect Dis. 2005 Nov 15;192(10):1741-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16235172</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Immunol Cell Biol. 2003 Jun;81(3):230-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12752688</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Genomics. 2003 Nov;82(5):537-52</Citation><ArticleIdList><ArticleId IdType="pubmed">14559211</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Rev Sci Tech. 1998 Apr;17(1):220-30</Citation><ArticleIdList><ArticleId IdType="pubmed">9638812</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Cytogenet Genome Res. 2005;111(1):51-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16093721</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Biol Chem. 1999 Sep 3;274(36):25535-42</Citation><ArticleIdList><ArticleId IdType="pubmed">10464285</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Med Sci Monit. 2005 Jul;11(7):BR235-47</Citation><ArticleIdList><ArticleId IdType="pubmed">15990685</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2002 Dec 5;420(6915):574-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12466852</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2156-61</Citation><ArticleIdList><ArticleId IdType="pubmed">14769939</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Mol Cell. 2003 Nov;12(5):1173-85</Citation><ArticleIdList><ArticleId IdType="pubmed">14636576</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Med Genet. 2006 Feb;43(2):129-32</Citation><ArticleIdList><ArticleId IdType="pubmed">16014697</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Biol Chem. 2006 Feb 24;281(8):4624-37</Citation><ArticleIdList><ArticleId IdType="pubmed">16371364</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 2007 Nov 25;368(2):232-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17904183</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Cell Mol Life Sci. 2002 Jul;59(7):1212-22</Citation><ArticleIdList><ArticleId IdType="pubmed">12222967</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Hum Genet. 2005 Apr;76(4):623-33</Citation><ArticleIdList><ArticleId IdType="pubmed">15732009</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2006 Mar;80(6):2987-99</Citation><ArticleIdList><ArticleId IdType="pubmed">16501108</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Cell Mol Life Sci. 2000 Oct;57(11):1593-612</Citation><ArticleIdList><ArticleId IdType="pubmed">11092454</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochim Biophys Acta. 1998 Jan 21;1395(2):181-91</Citation><ArticleIdList><ArticleId IdType="pubmed">9473666</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Epidemiol. 1967 Nov;86(3):765-75</Citation><ArticleIdList><ArticleId IdType="pubmed">6081390</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Interferon Cytokine Res. 1999 Apr;19(4):295-308</Citation><ArticleIdList><ArticleId IdType="pubmed">10334380</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Gene. 2001 Jun 27;271(2):261-71</Citation><ArticleIdList><ArticleId IdType="pubmed">11418248</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Genomics. 1998 Sep 15;52(3):267-77</Citation><ArticleIdList><ArticleId IdType="pubmed">9790745</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Mol Cell Biol. 1986 Dec;6(12):4770-4</Citation><ArticleIdList><ArticleId IdType="pubmed">3796617</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Mol Evol. 2006 Oct;63(4):562-76</Citation><ArticleIdList><ArticleId IdType="pubmed">17024523</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Mol Cell Biol. 2005 Jun;25(11):4615-24</Citation><ArticleIdList><ArticleId IdType="pubmed">15899864</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Genes Immun. 2003 Sep;4(6):411-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12944978</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2005 Apr 22;329(4):1234-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15766558</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6780-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8692895</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Adv Virus Res. 2003;60:43-85</Citation><ArticleIdList><ArticleId IdType="pubmed">14689691</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Eur J Biochem. 1998 Oct 15;257(2):319-30</Citation><ArticleIdList><ArticleId IdType="pubmed">9826176</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Japon</li></country></list><tree><noCountry><name sortKey="Guenet, J L" sort="Guenet, J L" uniqKey="Guenet J" first="J-L" last="Guénet">J-L Guénet</name><name sortKey="Simon Chazottes, D" sort="Simon Chazottes, D" uniqKey="Simon Chazottes D" first="D" last="Simon-Chazottes">D. Simon-Chazottes</name></noCountry><country name="Japon"><noRegion><name sortKey="Mashimo, T" sort="Mashimo, T" uniqKey="Mashimo T" first="T" last="Mashimo">T. Mashimo</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B07 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001B07 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:18727488
|texte= Innate resistance to flavivirus infections and the functions of 2'-5' oligoadenylate synthetases.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:18727488" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |